FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313461291> ?p ?o ?g. }

• W4313461291 abstract "Kidney renal papillary cell carcinoma (KIRP) has a high mortality rate and a poor prognosis. Cu concentrations differed significantly between renal cancer tissues and adjacent normal tissues. Cuproptosis is a newly identified cell death. Long non-coding RNAs (lncRNAs) play a crucial role in the progression of KIRP. In this study, we focused on constructing and validating cuproptosis-related lncRNA signatures to predict the prognosis of KIRP patients and their immune correlation. We created prognosis models using Cox regression analysis and the least absolute shrinkage and selection operator (LASSO) algorithm. We found that patients in the high-risk group had poorer overall survival (OS) and progression-free survival (PFS) and higher mortality. Risk score and stage are prognosis factors independent of other clinical features. Kaplan-Meier analysis, receiver operating characteristic (ROC) curves, and C-index curves showed that cuproptosis-related lncRNA signatures could more accurately predict the prognosis of patients. Functional enrichment analysis suggests that the function of differentially expressed genes (DEGs) is associated with KIRP development and immunity. In immune-related function analysis, we found a significant difference in parainflammation responses between high-risk and low-risk groups. The mutation frequencies of TTN, MET, KMT2C, PKHD1, SETD2, and KMT2D genes in the high-risk group were higher than those in the low-risk group, but the mutation frequencies of MUC16, KIAA109, CUBN, USH2A, DNAH8 and HERC2 genes were significantly lower than those in the low-risk group. Survival analysis of tumor mutation burden (TMB) and combined TMB-risk showed better OS in patients with high TMB. Immune infiltration and immune checkpoint analysis assessed the immune association of six high mutation frequency genes (TTN, MET, KMT2C, PKHD1, SETD2, and KMT2D) with KIRP. Finally, we performed a drug sensitivity analysis and screened 15 potential drugs that differed between high-risk and low-risk patients. In this study, we constructed and validated cuproptosis-related lncRNA signatures that can more accurately predict the prognosis of KIRP patients and provide new potential therapeutic targets and prognosis markers for KIRP patients." @default.
• W4313461291 created "2023-01-06" @default.
• W4313461291 creator A5004035476 @default.
• W4313461291 creator A5012341357 @default.
• W4313461291 creator A5025834611 @default.
• W4313461291 creator A5048287522 @default.
• W4313461291 creator A5048826252 @default.
• W4313461291 creator A5071037763 @default.
• W4313461291 creator A5075830264 @default.
• W4313461291 creator A5078167495 @default.
• W4313461291 date "2022-12-21" @default.
• W4313461291 modified "2023-10-05" @default.
• W4313461291 title "Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma" @default.
• W4313461291 cites W1855921321 @default.
• W4313461291 cites W2048873422 @default.
• W4313461291 cites W2058615058 @default.
• W4313461291 cites W2073435239 @default.
• W4313461291 cites W2096780363 @default.
• W4313461291 cites W2126547130 @default.
• W4313461291 cites W2146810218 @default.
• W4313461291 cites W2149668671 @default.
• W4313461291 cites W2209285888 @default.
• W4313461291 cites W2470477092 @default.
• W4313461291 cites W2761661840 @default.
• W4313461291 cites W2769505164 @default.
• W4313461291 cites W2896467275 @default.
• W4313461291 cites W2899490807 @default.
• W4313461291 cites W2905132833 @default.
• W4313461291 cites W2905953278 @default.
• W4313461291 cites W2909679049 @default.
• W4313461291 cites W2989633600 @default.
• W4313461291 cites W2996973313 @default.
• W4313461291 cites W3005722196 @default.
• W4313461291 cites W3007428792 @default.
• W4313461291 cites W3038633029 @default.
• W4313461291 cites W3039315006 @default.
• W4313461291 cites W3044477787 @default.
• W4313461291 cites W3048024025 @default.
• W4313461291 cites W3101496551 @default.
• W4313461291 cites W3112671651 @default.
• W4313461291 cites W3120988047 @default.
• W4313461291 cites W3129780093 @default.
• W4313461291 cites W3159425157 @default.
• W4313461291 cites W3162204645 @default.
• W4313461291 cites W3194040044 @default.
• W4313461291 cites W3196946968 @default.
• W4313461291 cites W3198985041 @default.
• W4313461291 cites W3213719240 @default.
• W4313461291 cites W4210600444 @default.
• W4313461291 cites W4212911042 @default.
• W4313461291 cites W4214862149 @default.
• W4313461291 cites W4220757518 @default.
• W4313461291 cites W4221115671 @default.
• W4313461291 cites W4280497443 @default.
• W4313461291 cites W4280512182 @default.
• W4313461291 cites W4283167656 @default.
• W4313461291 cites W4284973966 @default.
• W4313461291 cites W4286457143 @default.
• W4313461291 cites W4295706207 @default.
• W4313461291 doi "https://doi.org/10.3389/fphar.2022.1103986" @default.
• W4313461291 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36618928" @default.
• W4313461291 hasPublicationYear "2022" @default.
• W4313461291 type Work @default.
• W4313461291 citedByCount "3" @default.
• W4313461291 countsByYear W43134612912023 @default.
• W4313461291 crossrefType "journal-article" @default.
• W4313461291 hasAuthorship W4313461291A5004035476 @default.
• W4313461291 hasAuthorship W4313461291A5012341357 @default.
• W4313461291 hasAuthorship W4313461291A5025834611 @default.
• W4313461291 hasAuthorship W4313461291A5048287522 @default.
• W4313461291 hasAuthorship W4313461291A5048826252 @default.
• W4313461291 hasAuthorship W4313461291A5071037763 @default.
• W4313461291 hasAuthorship W4313461291A5075830264 @default.
• W4313461291 hasAuthorship W4313461291A5078167495 @default.
• W4313461291 hasBestOaLocation W43134612911 @default.
• W4313461291 hasConcept C104317684 @default.
• W4313461291 hasConcept C10515644 @default.
• W4313461291 hasConcept C121608353 @default.
• W4313461291 hasConcept C126322002 @default.
• W4313461291 hasConcept C143998085 @default.
• W4313461291 hasConcept C159641895 @default.
• W4313461291 hasConcept C203014093 @default.
• W4313461291 hasConcept C50382708 @default.
• W4313461291 hasConcept C54355233 @default.
• W4313461291 hasConcept C58471807 @default.
• W4313461291 hasConcept C71924100 @default.
• W4313461291 hasConcept C86803240 @default.
• W4313461291 hasConcept C8891405 @default.
• W4313461291 hasConceptScore W4313461291C104317684 @default.
• W4313461291 hasConceptScore W4313461291C10515644 @default.
• W4313461291 hasConceptScore W4313461291C121608353 @default.
• W4313461291 hasConceptScore W4313461291C126322002 @default.
• W4313461291 hasConceptScore W4313461291C143998085 @default.
• W4313461291 hasConceptScore W4313461291C159641895 @default.
• W4313461291 hasConceptScore W4313461291C203014093 @default.
• W4313461291 hasConceptScore W4313461291C50382708 @default.
• W4313461291 hasConceptScore W4313461291C54355233 @default.
• W4313461291 hasConceptScore W4313461291C58471807 @default.
• W4313461291 hasConceptScore W4313461291C71924100 @default.
• W4313461291 hasConceptScore W4313461291C86803240 @default.

• next